Myosin V and iNOS expression is enhanced in J774 murine macrophages treated with IFN-gamma.
Actin-based motor protein requirements and nitric oxide (NO) production are important features of macrophage activity during phagocytosis or microbicidal processes. Different classes of myosins contribute directly or indirectly to phagocytosis by providing mechanical force for phagosome closure or organelle movement. Recent data have shown the presence of myosins IC, II, V and IXb in phagosomes of bone marrow-derived murine macrophages. In our investigation we demonstrated the presence of different classes of myosins in J774 macrophages. We also analyzed the effect of gamma interferon (IFN-gamma), with or without calcium ionophore or cytochalasin B, on myosins as well as on inducible nitric oxide synthase (iNOS) expression and NO production. Myosins IC, II, Va, VI and IXb were identified in J774 macrophages. There was an increase of myosin V expression in IFN-gamma-treated cells. iNOS expression was increased by IFN-gamma treatment, while calcium ionophore and cytochalasin B had a negative influence on both myosin and iNOS expression, which was decreased. The increases in NO synthesis were reflected by increased iNOS expression. Macrophages activated by IFN-gamma released significant amounts of NO when compared to control groups. In contrast, NO production by calcium ionophore- and cytochalasin B-treated cells was similar to that of control cells. These results suggest that IFN-gamma is involved in macrophage activation by stimulating protein production to permit both phagocytosis and microbicidal activity.
Reis
D
D
Departamento de Imunologia, Microbiologia e Parasitologia, Universidade Federal de Uberlândia, Brasil.
Souza
M
M
Mineo
J
J
Espindola
F
F
D000818:Animals; D015153:Blotting, Western; D002148:Calmodulin-Binding Proteins / Q000187:drug effects* / Q000378:metabolism; D016022:Case-Control Studies; D002465:Cell Movement / Q000187:drug effects; D002478:Cells, Cultured; D003571:Cytochalasin B / Q000378:metabolism; D007371:Interferon-gamma / Q000494:pharmacology*; D007476:Ionophores / Q000378:metabolism; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D024701:Myosin Type V; D009218:Myosins / Q000187:drug effects; D009419:Nerve Tissue Proteins / Q000187:drug effects* / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000187:drug effects* / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II; D010587:Phagocytosis / Q000187:drug effects
D002148:Calmodulin-Binding Proteins; D007476:Ionophores; D009419:Nerve Tissue Proteins; C078829:chicken brain myosin-V p190; D009569:Nitric Oxide; D003571:Cytochalasin B; D007371:Interferon-gamma; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496317:Nos2 protein, mouse; D024701:Myosin Type V; D009218:Myosins